Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTC-801F for symptomatic bradyarrhythmias in pacemaker recipients (Phase II)
jRCT2051250264Phase 2Not yet recruiting
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bradyarrhythmia, sick sinus syndrome (SSS), atrioventricular block and 1 more comparing NTC-801F with Placebo (2 arms). Planned start May 2026; status: not yet recruiting.
02
Drugs
NTC-801F
03
Conditions
bradyarrhythmiasick sinus syndrome (SSS)atrioventricular blockAtrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2051250264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051250264.